Incyte Corporation growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +21.5%
EBITDA: +359.9%
EBIT: +602.5%
EPS: +1873.0%
Free cash flow: +402.4%
Operating cash flow: +296.4%

Forward estimates

Revenue: +8.5%
EBITDA: -33.1%
EPS: +15.1%

Three-year CAGR

Revenue: +14.8%
EBITDA: +43.2%
EBIT: +31.4%
Net income: +55.7%
EPS: +62.7%
Free cash flow: +14.9%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.